Chartwell Investment Partners LLC Sells 5,993 Shares of CME Group Inc (NASDAQ:CME)
Chartwell Investment Partners LLC lowered its stake in CME Group Inc (NASDAQ:CME) by 11.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 46,683 shares of the financial services provider’s stock after selling 5,993 shares during the period. Chartwell Investment Partners LLC’s holdings in CME Group were worth $7,588,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Wellington Management Group LLP increased its holdings in shares of CME Group by 6,150.5% during the first quarter. Wellington Management Group LLP now owns 2,126,309 shares of the financial services provider’s stock valued at $367,659,000 after acquiring an additional 2,092,291 shares in the last quarter. Viking Global Investors LP bought a new stake in CME Group during the first quarter worth $294,288,000. BlackRock Inc. grew its holdings in CME Group by 4.6% during the first quarter. BlackRock Inc. now owns 26,645,530 shares of the financial services provider’s stock worth $4,607,281,000 after buying an additional 1,179,970 shares in the last quarter. California Public Employees Retirement System grew its holdings in CME Group by 28.9% during the first quarter. California Public Employees Retirement System now owns 2,568,944 shares of the financial services provider’s stock worth $444,196,000 after buying an additional 576,402 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec grew its holdings in CME Group by 217.0% during the first quarter. Caisse DE Depot ET Placement DU Quebec now owns 827,944 shares of the financial services provider’s stock worth $143,160,000 after buying an additional 566,743 shares in the last quarter. Institutional investors own 84.83% of the company’s stock.
In related news, Director Timothy S. Bitsberger sold 600 shares of the business’s stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $191.32, for a total value of $114,792.00. Following the completion of the sale, the director now owns 9,927 shares in the company, valued at $1,899,233.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William R. Shepard purchased 1,229 shares of the stock in a transaction that occurred on Thursday, June 11th. The stock was purchased at an average price of $178.10 per share, with a total value of $218,884.90. Following the acquisition, the director now directly owns 2,000 shares of the company’s stock, valued at approximately $356,200. The disclosure for this purchase can be found here. Corporate insiders own 1.20% of the company’s stock.
CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 29th. The financial services provider reported $1.63 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.62 by $0.01. The company had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.20 billion. CME Group had a return on equity of 9.93% and a net margin of 46.39%. The firm’s revenue for the quarter was down 7.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.76 earnings per share. As a group, equities research analysts predict that CME Group Inc will post 7.15 earnings per share for the current fiscal year.
A number of brokerages have recently commented on CME. Rosenblatt Securities dropped their price target on CME Group from $140.00 to $130.00 and set a “sell” rating on the stock in a research report on Thursday. Goldman Sachs Group dropped their price target on CME Group from $175.00 to $170.00 and set a “neutral” rating on the stock in a research report on Monday, June 22nd. Deutsche Bank dropped their price objective on CME Group from $196.00 to $178.00 and set a “buy” rating on the stock in a report on Thursday. UBS Group upped their target price on CME Group from $222.00 to $225.00 and gave the stock a “buy” rating in a research note on Thursday, April 30th. Finally, Keefe, Bruyette & Woods lowered CME Group from a “market perform” rating to an “underperform” rating in a research note on Sunday, April 19th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the stock. CME Group has a consensus rating of “Hold” and an average price target of $187.88.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Article: How are institutional investors different from individual investors?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.